BiomX (PHGE) Enterprise Value (2018 - 2026)
BiomX (PHGE) posted Enterprise Value of -$493000.0 for Q1 2026, up 86.6% sequentially from -$3.7 million in Q4 2025, and up 97.66% YoY from -$249418.1 in Q1 2025.
BiomX (PHGE) Enterprise Value (2018 - 2026) Analysis & Trends
BiomX has reported Enterprise Value for 9 years, with the latest figure at -$493000.0 in Q1 2026.
- Quarterly Enterprise Value rose 97.66% year-over-year to -$493000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$493000.0 (up 97.66% YoY) and the FY2025 annual result came in at -$3.7 million, up 79.35% from the prior year.
- Enterprise Value rose to -$493000.0 in Q1 2026 per PHGE's latest filing, from -$3.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$493000.0 in Q1 2026 and troughed at -$38.0 million in Q2 2022.
- A 5-year average of -$21.1 million and a median of -$23.4 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value slipped 22.72% in 2022, then surged 97.81% in 2024.
- Over 5 years, Enterprise Value stood at -$31.4 million in 2022, then surged by 49.51% to -$15.9 million in 2023, then retreated by 12.29% to -$17.8 million in 2024, then jumped by 79.35% to -$3.7 million in 2025, then surged by 86.6% to -$493000.0 in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$493000.0, -$3.7 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 2.12 Bn |
| 10 | BiomX | 359,064.97 | -808,935.03 | - | -1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493,000.00 |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | -7.91 Mn |
| Jun 30, 2025 | -15.03 Mn |
| Mar 31, 2025 | -21.07 Mn |
| Dec 31, 2024 | -17.81 Mn |
| Sep 30, 2024 | -24.65 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Mar 15, 2024 | -663,000.00 |
| Dec 31, 2023 | -15.86 Mn |
| Sep 30, 2023 | -23.39 Mn |
| Jun 30, 2023 | -30.66 Mn |
| Mar 31, 2023 | -30.30 Mn |
| Dec 31, 2022 | -31.42 Mn |
| Sep 30, 2022 | -33.62 Mn |
| Jun 30, 2022 | -38.02 Mn |
| Mar 31, 2022 | -31.00 Mn |
| Dec 31, 2021 | -63.10 Mn |
| Sep 30, 2021 | -30.99 Mn |
| Jun 30, 2021 | -30.98 Mn |